APA (7th ed.) Citation

Vancheri, C., Kreuter, M., Richeldi, L., Quaresma, M., Stowasser, S., & Wuyts, W. A. (2018). Reply to Rajchgot et al., Combination Nintedanib and Pirfenidone for treatment of idiopathic pulmonary fibrosis. American journal of respiratory and critical care medicine, 198(8), . https://doi.org/10.1164/rccm.201806-1116LE

Chicago Style (17th ed.) Citation

Vancheri, Carlo, Michael Kreuter, Luca Richeldi, Manuel Quaresma, Susanne Stowasser, and Wim A. Wuyts. "Reply to Rajchgot Et Al., Combination Nintedanib and Pirfenidone for Treatment of Idiopathic Pulmonary Fibrosis." American Journal of Respiratory and Critical Care Medicine 198, no. 8 (2018). https://doi.org/10.1164/rccm.201806-1116LE.

MLA (9th ed.) Citation

Vancheri, Carlo, et al. "Reply to Rajchgot Et Al., Combination Nintedanib and Pirfenidone for Treatment of Idiopathic Pulmonary Fibrosis." American Journal of Respiratory and Critical Care Medicine, vol. 198, no. 8, 2018, https://doi.org/10.1164/rccm.201806-1116LE.